Antipsychotic-induced supersensitivity – A reappraisal

Comparative efficacy and tolerability of 32 oral antipsychotics for the acute treatment of adults with multi-episode schizophrenia: a systematic review and network meta-analysis

(2019) Maximilian Huhn et al.   LANCET

Randomised controlled trial of gradual antipsychotic reduction and discontinuation in people with schizophrenia and related disorders: the RADAR trial (Research into Antipsychotic Discontinuation and Reduction)

(2019) Joanna Moncrieff et al.   BMJ Open

20-Year Nationwide Follow-Up Study on Discontinuation of Antipsychotic Treatment in First-Episode Schizophrenia

(2018) Jari Tiihonen et al.   AMERICAN JOURNAL OF PSYCHIATRY

Antipsychotic-Induced Dopamine Supersensitivity Psychosis: Pharmacology, Criteria, and Therapy

(2017) Guy Chouinard et al.   PSYCHOTHERAPY AND PSYCHOSOMATICS

Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for the management of schizophrenia and related disorders

(2016) Cherrie Galletly et al.   AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY

Should psychiatrists be more cautious about the long-term prophylactic use of antipsychotics?

(2016) Robin M. Murray et al.   BRITISH JOURNAL OF PSYCHIATRY

Discontinuation vs. continuation treatment with neuroleptics for a better long-term outcome

(2016) L. Wunderink et al.   EUROPEAN PSYCHIATRY

Risk of symptom recurrence with medication discontinuation in first-episode psychosis: A systematic review

(2013) Robert B. Zipursky et al.   SCHIZOPHRENIA RESEARCH

Antipsychotic drugs versus placebo for relapse prevention in schizophrenia: a systematic review and meta-analysis

(2012) Stefan Leucht et al.   LANCET

Tardive dyskinesia is caused by maladaptive synaptic plasticity: A hypothesis

(2012) James T. Teo et al.   MOVEMENT DISORDERS

Chronic Treatment With Aripiprazole Prevents Development of Dopamine Supersensitivity and Potentially Supersensitivity Psychosis

(2011) S. Tadokoro et al.   SCHIZOPHRENIA BULLETIN